secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001104659-23-071024
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics shareholders pass all 10 proposals at 2023 AGM
-------------------------------------------------------------------

- Approximately 91.77% of outstanding ordinary shares voted; proposals passed with overwhelming support.
- All three director nominees (Bourque, Jordan, Winter) re-elected; Winter received 27.2M votes for.
- Advisory say-on-pay passed with 26.1M votes for vs. 1.97M against (93% approval).
- PwC ratified as US auditor (28.0M for) and reappointed as UK statutory auditor.
- Directors' remuneration policy approved with 26.1M for vs. 1.97M against (93% approval).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923071024/0001104659-23-071024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465923071024/tm2318664d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-071024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer